Skip to main content
. 2022 Sep 7;28(9):1324–1331. doi: 10.1089/tmj.2021.0420

Table 2.

Most Prevalent Comorbidities Present in the Opt-In and Opt-Out Groups

COHORT TOTAL PATIENTS CARDIOVASCULAR DISEASE [PERCENTAGE OF TOTAL] DIABETES MELLITUS [PERCENTAGE OF TOTAL] HYPERTENSIVE DISEASE [PERCENTAGE OF TOTAL] MOOD DISORDERS [PERCENTAGE OF TOTAL]
Opt-in group 2,242 1,499 [66.9] 766 [34.2] 1,607 [71.7] 872 [38.9]
Opt-out group 1,540 604 [39.2] 406 [26.4] 702 [45.6] 367 [23.9]